Biotech Stocks Declining (AGEN, DNDN, GILD, VVUS, CTIC, AEZS)

Antigenics, Inc. (NASDAQ:AGEN) plunges 15.44% to $1.15. The company announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Dendreon Corporation (NASDAQ:DNDN) lost 2.71% to $41.26.

Gilead Sciences, Inc. (NASDAQ:GILD) drops 4.36% to $37.30.

VIVUS, Inc. (NASDAQ:VVUS) declines 4.82% to $11.66 on 1.85 million shares.

Cell Therapeutics, Inc. (NASDAQ:CTIC) drops 6.76% to $0.457 on 1.49 million shares. Cell Therapeutics, Inc. develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs.

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) decreases 2.25% to $1.74 on 1.73 million shares.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.